The purpose of this study is to evaluate of the safety, efficacy, pharmacokinetics (PK) and pharmacodynamic (PD) effects of lumacaftor...
Ursodeoxycholic acid is indicated in the treatment of primary biliary cirrhosis (PBC) and for the dissolution of radiolucent gallstones in patients with a functioning gall bladder. Paediatric population Hepatobiliary disorders associated with cystic fibrosis in children aged 6 to 18 years.
Lexicon Pharmaceuticals, Inc. announced that the European Commission has approved Xermelo (telotristat ethyl) 250 mg as a first and only...